Lance Thibault

Lance Thibault

Lance brings more than 30 years of experience as a life science CFO and senior executive to his work for Danforth clients. As the head of our Accounting and Reporting Advisory practice, he oversees service in the areas of IPO preparation, audit readiness, post-public SEC compliance, and other technical accounting and financial reporting needs. Prior to joining Danforth, Lance spent ten years as CFO leading a US public biotech company. He previously spent 12 years with PricewaterhouseCoopers, where he was an integral member of the Transaction Advisory Services Global Capital Markets Group in London, England. He is a sought-after advisor in complex GAAP matters, including convertible debt and preferred equity instruments, warrants and other derivatives, pharma collaborations, business acquisitions, technology licensing and stock-based compensation.

Lance is a CPA and holds a BS in Accountancy from Bentley University.

Select Achievements

  • Led preparation and execution of 12 successful US domestic and cross-border IPOs since 2013
  • Served as Interim CFO leading the US IPO of a Cambridge-based life science company
  • Served as Interim CFO of a life science SEC registrant and CFO of a Nasdaq-listed public company

Specialties

IPO preparation
Public company readiness
Financial statements, audit support and SEC financial reporting
Complex GAAP with respect to life science companies
SOX and ICFR